Sorbent augmented dialysis: minor addition or major advance in therapy?
Winchester
J F
JF
RenalTech International, New York, NY, 10021 USA. jamesw@renaltech.com
Ronco
C
C
Brady
J A
JA
Golds
E
E
Clemmer
J
J
Cowgill
L D
LD
Muller
T E
TE
Levin
N W
NW
D000284:Administration, Oral; D000327:Adsorption; D000818:Animals; D001798:Blood Proteins / Q000737:chemistry; D002606:Charcoal / Q000008:administration & dosage; D020099:Coated Materials, Biocompatible; D004285:Dogs; D006464:Hemoperfusion / Q000379:methods; D006801:Humans; D008567:Membranes, Artificial; D008863:Microspheres; D008970:Molecular Weight; D010316:Particle Size; D010530:Peritoneal Dialysis / Q000379:methods; D016062:Porosity; D011205:Povidone; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D012117:Resins, Synthetic / Q000737:chemistry; D016060:Sorption Detoxification / Q000379:methods*; D013213:Starch / Q000008:administration & dosage; D014511:Uremia / Q000097:blood / Q000628:therapy*; D001613:beta 2-Microglobulin / Q000737:chemistry
D001798:Blood Proteins; D020099:Coated Materials, Biocompatible; D008567:Membranes, Artificial; D012117:Resins, Synthetic; D001613:beta 2-Microglobulin; D002606:Charcoal; D013213:Starch; D011205:Povidone